News
Aclaris slashes staff as it trims its pipeline
Aclaris Therapeutics has said it will cut 46% of its workforce after …
19762 items found
Market Access
NICE and orphan drug recommendations: Should we be more worried about non-submissions?
Leela Barham uses the very latest data – running up to November 2023 …
News
FDA OKs test to spot patients at risk of opioid use disorder
A test that can be given to patients before they are prescribed a …
Market Access
Nine for 2024, Pt 1: From fragility to resilience
This year was a year of significant new beginnings for pharma and …
News
BioNTech wins round in CureVac mRNA patent dispute
Shares in CureVac have plummeted after a German court ruled that a …
News
Biogen bonus as generic Tecfidera approvals are pulled in EU
The European Commission has pulled marketing authorisations for …
Digital
Around the world in pharma events
Stay up to date with key industry meetings and conferences in 2023/24 …
News
Owkin and MSD join forces on AI-powered digital pathology
Pharma group MSD has joined forces with Owkin to develop artificial …
News
Novo Nordisk Foundation puts $260m into vaccine drive
The Novo Nordisk Foundation (NNF) is funding a major new R&D …
Digital
Why digital therapeutics (DTx) are effective and safe, but not being prescribed
In a new episode of the pharmaphorum podcast, host Nicole Raleigh …
R&D
Bioanalytical labs need to reimagine data to streamline their operations
The fundamental questions in the trial phases of drug development are …
News
FDA says no to Checkpoint’s skin cancer drug cosibelimab
Checkpoint Therapeutics’ late entry into the PD-1/PD-L1 inhibitor …
News
Teva fined €462.6m for antitrust delay to MS drug rivals
The European Commission has delivered a hefty fine to Teva for abusing a dominant position in multiple sclerosis by artificially extending the patent protection for former blockbuster Copax
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
A journey from personal to public: Digital health passports ...
A digital health passport is an app, or online certification, that displays a traveller’s health or vaccination record. It can save lives, on both private and public levels.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
Less than three weeks away: Join Global Experts at Transderm...
11-12 November 2024 in London, UK
R&D
Partner Content
4th mRNA Analytical Development & Quality Control Summit | F...
Excitement for mRNA therapeutics continues, as RNA technologies are awarded the Nobel Prize for the second year running.
